Network Insights Methodology Get Access

Sanofi

ORG Health Care / Pharmaceuticals Momentum 9.2ML Momentum Score (0-100). Weighted composite of 9 features: mention velocity, article breadth, relationship density, deal context, recency, market cap, enrichment completeness, mention concentration, entity type. NORMALPSI regime classification. QUIET (<0.3): baseline activity. NORMAL (0.3-0.5): typical deal flow. ELEVATED (0.5-0.7): above-average signals. HIGH (0.7-0.85): significant activity. EXTREME (>0.85): exceptional signal concentration. Primary: Spectral Shift

$54.8B revenue (Paris) manufactures vaccines, specialty care, and oncology therapeutics across 100+ countries. Recent focus on AI-powered precision medicine partnerships with biotech startups including Owkin platform for cancer decision support.

Investor in Owkin AI platform; Waiv spinout from Owkin signals pharma interest in precision oncology AI tools
-0.35
PSI ScorePlocamium Signal Index - composite z-score from 5 orthogonal signals: news frequency, targeted sentiment, graph centrality, regulatory filings, and clinical trial activity.
9.2
MomentumML Momentum Score (0-100). Weighted composite of 9 features including mention velocity, article breadth, deal context, and relationship density. Retrained weekly.
1%
ConfidenceSignal confidence - percentage of PSI sub-signals with sufficient data (30+ observations). Higher confidence means the PSI score is based on more complete data.
4
ConnectionsDegree centrality - number of unique entities this entity co-occurs with in news signals and articles. Higher = more connected in the intelligence network.
Connected Entities
FDA Europe Merck AstraZeneca
Watch This Entity
PSI Intelligence
30-Day Trend
2026-04-25 2026-05-25 5 0 Degree Mentions
Signal Decomposition
Attention Cascade
-0.719
Narrative Drift
0.000
Spectral Shift
624.046
Sentiment-Momentum Divergence
0.000
Source Concentration
0.944
Peer Comparison
Not yet ranked. Sector-relative scoring requires at least four entities in the same BICS sector with PSI history; this entity does not yet meet the threshold or sits in a sector with insufficient peers.
Network Analysis
4 Degree Centrality
Ego Network (top connections)
FDA (weight 7.0)Europe (weight 4.0)Merck (weight 4.0)AstraZeneca (weight 2.0) FDAEuropeMerckAstraZeneca Sanofi (degree 4) Sanofi
Centrality History
2026-04-25 2026-05-25 5 0 Degree Mentions
EntityWeight StatusFirst Seen
FDA 7 NEW
Europe 4 NEW
Merck 4 NEW
AstraZeneca 2 NEW
Article Coverage (0)
DateLaneTitle
No Plocamium-authored coverage yet. This entity surfaces in upstream signals (news, filings, trials) but has not yet been a primary subject of a published article. Watch this entity to be alerted when one is published.

Request Access

Full PSI intelligence, network analysis, EDGAR filings, and predicted links require an access token.

Data as of 2026-05-25 ← Intelligence Network